🔗 Visit the ClinicalTrials.gov page for NCT02658981
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Recent Advances in Immunotherapy in Metastatic NSCLC. | Front Oncol | 2016 | 0.79 |
| 2 | Recent advances and future of immunotherapy for glioblastoma. | Expert Opin Biol Ther | 2016 | 0.77 |
| 3 | Lymphocyte-activation gene-3, an important immune checkpoint in cancer. | Cancer Sci | 2016 | 0.76 |